OrganiGram (OGI)
(Delayed Data from NSDQ)
$1.74 USD
+0.01 (0.58%)
Updated Oct 16, 2024 04:00 PM ET
After-Market: $1.73 -0.01 (-0.57%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth D Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$1.74 USD
+0.01 (0.58%)
Updated Oct 16, 2024 04:00 PM ET
After-Market: $1.73 -0.01 (-0.57%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth D Momentum B VGM
Zacks News
Earnings Preview: OrganiGram (OGI) Q4 Earnings Expected to Decline
by Zacks Equity Research
OrganiGram (OGI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Levi Strauss, OrganiGram Holdings, United Natural Foods, Sprouts Farmers Market and Performance Food Group highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Levi Strauss, OrganiGram Holdings, United Natural Foods, Sprouts Farmers Market and Performance Food Group highlighted as Zacks Bull and Bear of the Day
Bear of the Day: OrganiGram Holdings (OGI)
by Madeleine Johnson
This cannabis stock is still being weighed down by the coronavirus pandemic.
OrganiGram (OGI) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
OrganiGram (OGI) delivered earnings and revenue surprises of -200.00% and -26.82%, respectively, for the quarter ended February 2021. Do the numbers hold clues to what lies ahead for the stock?
OrganiGram (OGI) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
OrganiGram (OGI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Inside the Top-Performing ETFs of Q1
by Sweta Killa
Amplify Seymour Cannabis ETF (CNBS) topped the list of the best-performing ETFs of February with impressive returns of about 60%.
OrganiGram (OGI) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
OrganiGram (OGI) closed at $4.40 in the latest trading session, marking a -0.9% move from the prior day.
Are Options Traders Betting on a Big Move in Organigram Holdings (OGI) Stock?
by Zacks Equity Research
Investors need to pay close attention to Organigram Holdings (OGI) stock based on the movements in the options market lately.
OrganiGram (OGI) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
OrganiGram (OGI) closed at $3.03 in the latest trading session, marking a -1.62% move from the prior day.
Is the Options Market Predicting a Spike in OrganiGram (OGI) Stock?
by Zacks Equity Research
Investors need to pay close attention to OrganiGram (OGI) stock based on the movements in the options market lately.
Cannabis Stocks Rise on Hopes of Federal Legalization in US
by Zacks Equity Research
Cannabis stocks seem poised to gain on hopes of removal of the federal ban on cannabis products under the new administration.
Organigram Holdings Inc. (OGI) Reports Q1 Loss, Misses Revenue Estimates
by Zacks Equity Research
Organigram Holdings Inc. (OGI) delivered earnings and revenue surprises of -300.00% and -8.34%, respectively, for the quarter ended November 2020. Do the numbers hold clues to what lies ahead for the stock?
Will OrganiGram (OGI) Report Negative Earnings Next Week? What You Should Know
by Zacks Equity Research
OrganiGram (OGI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is the Options Market Predicting a Spike in OrganiGram (OGI) Stock?
by Zacks Equity Research
Investors need to pay close attention to OrganiGram (OGI) stock based on the movements in the options market lately.
OrganiGram (OGI) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
OrganiGram (OGI) delivered earnings and revenue surprises of 0.00% and 2.79%, respectively, for the quarter ended August 2020. Do the numbers hold clues to what lies ahead for the stock?
OrganiGram (OGI) Surges: Stock Moves 8.9% Higher
by Zacks Equity Research
OrganiGram (OGI) saw a big move last session, as its shares jumped nearly 9% on the day, amid huge volumes.
Will OrganiGram (OGI) Report Negative Q4 Earnings? What You Should Know
by Zacks Equity Research
OrganiGram (OGI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Nike, OrganiGram, Thermo Fisher, Danaher Corp and Agilent Tech highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Nike, OrganiGram, Thermo Fisher, Danaher Corp and Agilent Tech highlighted as Zacks Bull and Bear of the Day
Bear of the Day: OrganiGram Holdings (OGI)
by Madeleine Johnson
Revenue and profits have fallen significantly year-over-year for this cannabis stock.
New Strong Sell Stocks for September 11th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today.
OrganiGram (OGI) Reports Break-Even Earnings for Q3
by Zacks Equity Research
OrganiGram (OGI) delivered earnings and revenue surprises of 100.00% and -20.81%, respectively, for the quarter ended May 2020. Do the numbers hold clues to what lies ahead for the stock?
OrganiGram (OGI) to Report Q3 Earnings: What's in Store?
by Zacks Equity Research
OrganiGram (OGI) is expected to have benefited from its focus on building brand equity and product launches in the fiscal third quarter despite pandemic-hit business conditions.
Do Options Traders Know Something About Organigram (OGI) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Organigram (OGI) stock based on the movements in the options market lately.
Organigram (OGI) Catches Eye: Stock Jumps 11.7%
by Zacks Equity Research
Organigram (OGI) saw a big move last session, as its shares jumped nearly 12% on the day, amid huge volumes.
OrganiGram (OGI) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
OrganiGram (OGI) delivered earnings and revenue surprises of -100.00% and -15.60%, respectively, for the quarter ended February 2020. Do the numbers hold clues to what lies ahead for the stock?